Insilico Medicine, a clinical stage biotech company, utilizes generative AI to connect biology, chemistry, and clinical trials analysis. Their AI platforms incorporate deep generative models, reinforcement learning, transformers, and other modern machine learning techniques. This aids in the discovery of novel targets and the generation of molecular structures with desired properties. Insilico Medicine focuses on developing innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company's Pharma.AI platform accelerates drug discovery and development across biology, chemistry, and clinical development. Insilico Medicine is at the forefront of generative AI-driven biotech in terms of AIDD pipeline progress.
Insilico Medicine stock is not currently traded in the private markets. We do not have enough data to print a price history for Insilico Medicine right now.
If you can share any Insilico Medicine stock trade data or funding round price per share, then we can start pricing coverage for Insilico Medicine.
Insilico Medicine Valuation
We are missing all Insilico Medicine funding round valuations. Sometimes these details are not shared in funding announcements or corporate filings.
If you can share valuations for any funding rounds that Insilico Medicine has done, then we can start valuation coverage for Insilico Medicine.
Insilico Medicine IPO
Insilico Medicine has not announced an official IPO date, IPO stock price, or filed a registration statement Form S-1 with the SEC. The Insilico Medicine IPO timeline is unknown.
An IPO for Insilico Medicine will likely need to clear the internal qualified public offering criteria in order receive shareholder approval.
When Insilico Medicine is ready to go public, they can IPO, SPAC or Direct List.
Does Insilico Medicine have stock?
Yes.
Investors usually get preferred stock and employees typically get common stock options or restricted stock units.
How to buy Insilico Medicine stock?
Insilico Medicine stock does not trade publicly on Nasdaq or NYSE because it is still a private company. Accredited investors are permitted to buy Insilico Medicine stock pre-IPO.
Private market transactions can be complex and often involve company approvals, legal purchase agreements and wires to third parties.
Trades can take 30 - 60 days to complete and that's why many investors hire experienced private market brokers to ensure things go smoothly. Notice members can message expert brokers for free to learn more about buying and selling private stocks.
What is the Insilico Medicine Stock Symbol?
Insilico Medicine does not have stock symbol nor does it trade in the public stock market because it is not a public company.
Insilico Medicine will choose a stock symbol or stock code prior to IPO.
Insilico Medicine will appear in the Notice stock ticker if it has recent private market activity.
Join Notice
We offer free access to the best private market intelligence available because we think everyone deserves to know the value of their private stock.